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n/a	 n/a	 n/a	 1.13	 1.03-1.25	
	




























































































































































































































































































































-0.30	 0.900	 n/a	 n/a	 n/a	 n/a	 0.90	 0.001	































































































































































































































































































































































































































































































































































































































































Beds/Hospital	trust	 -0.07	 0.43	 -0.04	
	
0.66	
Teaching	Hospital	status	 0.10	 0.25	 0.07	 0.40	












Overall	CQC	score	 0.09	 0.30	 0.05	 0.54	
NHS	Litigation	Authority	claims	 -0.16		 0.10	 0.06	 0.55	
NHS	Litigation	Authority	claims/bed		 -0.15	 0.12	 0.06	 0.52	
NHS	Litigation	Authority	
payments/bed	
-0.12	 0.25	 0.08	 0.45	






































Factor	 B	Coefficient	 P	value	 Confidence	intervals	
Teaching	Hospital	status	 0.74	 0.16	 -0.27	to	1.75	
Clinicians/bed	 -2.67	 0.08	 -5.66	to	0.33	
Nurses/bed	 0.81	 0.32	 -0.79	to	2.40	
SHMI	 -0.54	 0.72	 -3.54	to	2.45	
Overall	CQC	score	 0.03	 0.27	 -0.03	to	0.09	






























Factor	 B	Coefficient	 P	value	 Confidence	intervals	
Teaching	Hospital	status	 0.12	 0.65	 -0.40	to	0.65	
Clinicians/bed	 -1.78	 0.03	 -3.33	to	-0.23	
Nurses/bed	 0.82	 0.05	 -0.01	to	1.64	
SHMI	 -0.41	 0.61	 -2.00	to	1.15	
Overall	CQC	score	 0.02	 0.14	 -0.01	to	0.05	
NHS	Litigation	Authority	claims/bed	 9.30	 0.01	 2.04	to	16.54	



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Vascular	surgery	 17	 7	 5	 0	
“Other”	 1879	 660	 60	 23	
Trauma	and	orthopaedics	 613	 188	 19	 15	
Urology	 79	 25	 9	 2	
General	surgery	 904	 229	 28	 14	
Ophthalmology	 186	 73	 5	 0	
Cardiothoracic	surgery	 93	 35	 12	 4	
Neurosurgery	 60	 26	 6	 1	
Colorectal	surgery	 11	 9	 1	 0	
ENT	 113	 23	 3	 1	
Plastic	surgery	 61	 13	 3	 0	
Maxillofacial	/	oral	surgery	 43	 10	 2	 1	
Breast	surgery	 29	 10	 1	 0	
Dental	surgery	 4	 2	 0	 0	
Renal	surgery	 2	 0	 0	 0	















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































7.2 INTRODUCTION		 	7.2.1 What	is	avoidable	mortality?	
Avoidable	mortality	can	be	defined	as	a	death	that	should	not	occur	given	current	medical	
knowledge	 or	 technology.[374]	 Charlton	 and	 colleagues	 originally	 described	 avoidable	
mortality	in	1983	by	compiling	a	list	of	diseases	considered	treatable	and	then	investigating	














Measures	 of	 risk-adjusted	 mortality	 such	 as	 Summary	 Hospital	 Mortality	 Indicator	 and	











The	 avoidable	 nature	 of	 an	 inpatient	 death	 has	 traditionally	 been	 assessed	 through	














they	did	not	specifically	 study	 the	proportion	of	deaths	 that	were	avoidable.[200]	A	more	
recent	Dutch	study	using	retrospective	case	note	review	suggested	the	proportion	of	deaths	
that	 had	 an	 adverse	 event	 associated	 with	 them	 was	 4.1%.[383]	 Hogan	 and	 colleagues	




























































































































1	 2	 3	 4	 5	
Did	any	aspiration	event	occur?	








1	 2	 3	 4	 5	
Did	a	hospital	acquired	pressure	ulcer	develop	or	
advance?	 1	 2	 3	 4	 5	
Did	a	hospital-acquired	infection	develop?	 1	 2	 3	 4	 5	
Did	a	problem	in	healthcare	lead	to	a	fall	taking	place?	 1	 2	 3	 4	 5	
Did	a	surgical/procedural	complication	cause	harm?	 1	 2	 3	 4	 5	
Did	an	unplanned	return	to	theatre	occur?	 1	





1	 2	 3	 4	 5	
Did	an	adverse	event	lead	to	the	cardiac	arrest?	
	 1	 2	 3	 4	 5	
Did	any	other	adverse	events	occur?	

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































NRLS:  No Harm 
  Low Harm 
  Moderate Harm 
  Severe Harm  
  Death 
 
NCC MERP: A Events occurred that have the capacity to cause error 
  B An error occurred but the error did not reach the patient 
  C An error occurred that reached the patient but did not cause harm 
D An error occurred that reached the patient and required monitoring to 
confirm that it resulted in no harm to the patient 
 
 
E Temporary harm to the patient and required intervention 
F Temporary harm to the patient and required initial or prolonged 
hospitalization 
G Permanent patient harm 
H Intervention required to sustain life 












































































































































































	! "# = ! #" ! "! # 	
§ where	A	and	B	are	events	and	!(#) ≠ (	















































































































a) Combine similar phrases into one feature 
For example: "delay in treatment" and "treatment was delayed". 
 
b) Include different morphologies of the same lexemes ("fall", "falls", "fell", "fallen") and 
different forms of phrasing not found in the original set of phrases ("patient fell", "patient 
had fallen") 
 
c) Include synonyms ("drug", "medication"), spelling variants or ("pt", "patient"), and words in 
similar semantic categories ("hand", "arm", "wrist", "finger") 
 
d) Search for further synonyms 
For example: identifying drugs by the regular expression /(0-9)+mg of (a-z)+/ 
 
e) Identify homonymous terms and exclude or add context.  
For example: “IUD” could be used for Intra-Uterine Device or Intra Uterine Death 
 
f) Identify polysemes and exclude or add context. 
For example: harm class allocated to “dead” for “dead battery” vs. “dead patient” 
 
g) Express features as regular expressions  
For example:      (could|should|might) (have|of) been  (avoided|prevented|caused) 
units|unit (of)?blood|transfus\w+ 
 
h) Group larger features together 















































• Precision:	also	known	as	the	positive	predictive	value	!!) = *!*! + ,!	
• Recall:	also	known	as	the	sensitivity	or	true	positive	rate		*!- = *!*! + ,.	






























NO	HARM	 541	 82	 155	 222	 0.868	 0.709	 0.781	
HARM	 155	 222	 541	 82	 0.411	 0.654	 0.505	
Weighted	
average	


























Incident 1: Example of a harm report misclassified by the NRLS as “NO 
HARM” 
 
NRLS Harm level chosen:  “No Harm” 
 
NRLS Free Text: 
 
“Patient was brought to a and e as a collapse during admission patient suffered a cardiac arrest 
and after several resus attempts died. I was then informed by staff he had been in a and the 
previous evening with a collapse and discharged by the locum reg on checking previous CAS 
card it was documented that patient had severe dehydration and plan was discharge home . 
I was concerned re this incident and the following morning informed sister and dr of my 
concerns and gave them a copy of the cas cards from both days . The consultant on the day 
locum was informed at the time . .” 		
Incident 2: Example of a no harm report misclassified by the NRLS as 
“HARM” 
 
NRLS Harm level chosen: Moderate Harm 
 
NRLS Free Text: 
 

















Precision	 Recall	 F-Measure	 ROC	
Area	
1	 NO	HARM	 0.28	 0.118	 0.884	 0.28	 0.426	 0.699	
	 HARM	 0.882	 0.72	 0.276	 0.882	 0.42	 0.699	
	 Weighted	
Average	
0.423	 0.261	 0.74	 0.423	 0.425	 0.699	
2	 NO	HARM	 0.51	 0.181	 0.9	 0.51	 0.651	 0.763	
	 HARM	 0.819	 0.49	 0.342	 0.819	 0.482	 0.763	
	 Weighted	
Average	
0.583	 0.255	 0.768	 0.583	 0.611	 0.763	
3	 NO	HARM	 0.734	 0.211	 0.918	 0.734	 0.816	 0.831	
	 HARM	 0.789	 0.266	 0.479	 0.789	 0.596	 0.831	
	 Weighted	
Average	
0.747	 0.224	 0.814	 0.747	 0.764	 0.831	
4	 NO	HARM	 0.784	 0.241	 0.913	 0.784	 0.843	 0.834	
	 HARM	 0.759	 0.216	 0.522	 0.759	 0.619	 0.834	
	 Weighted	
Average	
0.778	 0.235	 0.82	 0.778	 0.79	 0.834	
5	 NO	HARM	 0.845	 0.266	 0.911	 0.845	 0.877	 0.849	
	 HARM	 0.734	 0.155	 0.596	 0.734	 0.658	 0.849	
	 Weighted	
Average	
0.819	 0.239	 0.836	 0.819	 0.825	 0.849	
6	 NO	HARM	 0.845	 0.266	 0.911	 0.845	 0.877	 0.849	
	 HARM	 0.734	 0.155	 0.596	 0.734	 0.658	 0.849	
	 Weighted	
Average	
0.819	 0.239	 0.836	 0.819	 0.825	 0.849	
7	 NO	HARM	 0.848	 0.266	 0.911	 0.848	 0.878	 0.852	
	 HARM	 0.734	 0.152	 0.6	 0.734	 0.66	 0.852	
	 Weighted	
Average	



















































































































































difficule CDT	(	positive cloristrium	difficile clostridium	dffiicle Clostridium	difficiel
clos.diff CDif cdifff Clost.difficile
Clossridium	
difficile c.difficil clostridum	deficile










C.	Diff C	Dif Closstidium	difficle clostrium	difficle
Clostridium	
deficiency Clos	difficile closridium	difficle





C	-	Dif Clost	difficile C.	Defficile CDT	+	Pos C.	Difficil Clostridium	diificle clostrium	diifficle
c	.	diff C~-|Dif
Clostriolimu	
Difficile CDT	positiive Clost	.	Difficile c.diffecile
closteridium	
difficile











































deficile CDT	positve c	,	/	,	diff Clostidium	difficlie Clotridium	Difficile
Clostridium	Difficle poss	CDT posiitve	for	cdt lostridium	Difficil C	'	diff
clostridium	
diffecile c	;	diff



















































































































































_______________________		 	 ________________		 	 ________________		
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This quest ionnaire is  part  of  a research study regarding the Nat ional  Report ing and Learning System, the pat ient
safety inc ident  report ing system for  heal thcare in England and Wales.
 
The aim of  th is study is  to explore the v iews of  experts and to reach a consensus regarding the ro le and aims of
inc ident  report ing wi th in heal thcare.  
You have been ident i f ied as an expert  wi th in the f ie ld of  pat ient  safety inc ident  report ing based on your peer-
reviewed publ icat ions.   We hope that  you wi l l  agree to take part  in th is study as your v iews wi l l  s igni f icant ly
contr ibute to determining the future ro le of  report ing in heal thcare.
 
Al l  v iews expressed wi l l  be t reated as conf ident ia l .   Once the resul ts of  the survey have been analyzed,  the same
quest ions wi l l  be asked, but  wi th the v iews of  other experts anonymously inc luded so that  you have the
opportuni ty to revise your answer or  provide comments.
  
 





Department of Surgery and Cancer
Imperial  College London
Aims and scope of incident report ing in healthcare systems.
Measuring the incidence of adverse events in healthcare.
 
What methods of  measur ing the harm that  occurs in hospi ta ls are the most val id and re l iable,  in your opin ion?
(please drag opt ions into your preferred order;  1=most re l iable,  7=least)
Aim and scope of patient safety incident reporting in healthcare.
 
These quest ions aim to c lar i fy  the most effect ive use of  the informat ion col lected by report ing systems.
Retrospective, expert, medical case note review
Retrospective, medical case note review using 'trigger tools' or similar explicit criteria
Hospital Mortality Statistics (e.g. Hospital Standardised Mortality Ratio (HSMR) or Standardised Hospital Mortality Index (SHMI))
Voluntary incident reporting systems
Mandatory incident reporting systems, detecting selected types of harm
Harm measured by hospital electronic database records (e.g. Hospital Episode Statistics, AHRQ Patient Safety Indicators).
Prospective observation of selected care processes. (e.g. prospective surveillance for pressure ulcers or hospital acquired infections)
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Based on your knowledge of  the capabi l i t ies and capaci ty of  current  report ing systems please indicate your level
of  agreement wi th the fo l lowing statements
   Strongly disagree Disagree
Neither Agree nor
Disagree Agree Strongly Agree
Reporting system data should be used to measure
the national incidence of harm (e.g. within the
National Health Service )
  
Voluntary reporting systems should be used to
measure the rate of harm in a hospital.   
Mandatory reporting systems should be used to
measure the rate of specific types of reported harm
(e.g. wrong site surgery) in a hospital.
  
Reporting systems should be used to identify unsafe
hospitals   
Reporting systems should be used to identify unsafe
healthcare professionals. (e.g. doctors and nurses)   
Reporting systems are a valid and reliable measure of
how safe a hospital is.   
Reporting systems should be used to identify the
types of safety problems that exist.   
Reporting system data should be used as indicators
of the safety culture of a hospital   
Reporting systems should be used to detect rare
events not picked up by other methods.   
Reporting systems should be used to share learning
between hospitals.   
Any fur ther comments that  you th ink may be re levant?
What should be reported
What should be reported to a patient safety incident system?
 
These quest ions aim to c lar i fy  what types of  inc ident  report  wi l l  provide the most effect ive learning mechanism
for pat ient  safety in hospi ta ls.
Please indicate your level  of  agreement wi th the fo l lowing statements regarding the type of  inc ident  report  that
should be col lected.




nor Disagree Agree Strongly Agree
Reporting systems should focus on events that cause harm to
patients.   
Reporting systems should only collect events where harm that
occurred was preventable.   
There should be mandatory reporting of “never events” or “serious
events” such as wrong site surgery.   
There should be specific criteria for what to report.   
Complaints about other members of staff, staffing or rota issues do
not constitute patient safety incidents and hence should not be
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Hospital number
Patient age
Time and date of incident
Location of incident
Consultant/attending in charge of care
National identifying number (e.g. NHS number or social security number)
Specialty caring for patient
Other
Near misses or no harm events should not be reported   
Reports should objectively classify what harm was caused and not
the potential for harm   
Adverse event classification systems should be standardized to allow
comparisons.   
Reports should contain patient identifiers so they can be linked to
other datasets.   
Incident reports should describe what happened and not why it
happened.   
Fewer and better described incidents should be encouraged,
compared to more and less well described ones.   
Events from Morbidity and Mortality meetings should be reported to a
national system.   
Al l  report ing systems should have a minimum dataset ,  contain ing the fo l lowing opt ions:  (Tick a l l  that  apply)
Feedback and learning
Feedback to staff and learning from patient safety incident reports
These quest ions aim to determine how indiv idual  feedback to staff  on reported incidents and learning f rom
incidents can be opt imised.
Please indicate your level  of  agreement wi th the fo l lowing statements regarding feedback and learning f rom
reported incidents.
   Strongly disagree Disagree
Neither Agree nor
Disagree Agree Strongly Agree
Reporting systems should give individual feedback to reporters   
The quality of incident reports submitted to a reporting system
is more important for learning than the quantity of reported
events
  
Anonymous reporting data should be readily available to
research groups for analysis.   
Incident reports should be used in educational programs for
trainees to promote quality improvement   
Staff should be encouraged to propose solutions for events at
the time of the report   
All reporters should have the option to keep their report
anonymous so that they are not identified.   
		 283	
	
08/06/2016, 14:00Qualtrics Survey Software
Page 4 of 8https://imperial.eu.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
For which of  the fo l lowing types of  reported incident  is  indiv idual  feedback appropr iate and feasib le? (Please t ick
the type of  feedback that  is  most  sui table for  the report)
You can choose more than one opt ion.




Specific feedback on the incident
after it has been
investigated/analyzed
Generic educational feedback related to the type of





Never events or serious
events (e.g. wrong site
surgery)
 
Incidents leading to death  
All incidents leading to
harm  
Near miss incidents (no




medication reactions  
Hospital acquired infection
incidents  
Who should provide indiv idual  feedback to reporters for  the types of  inc idents ment ioned?














Never events or serious events (e.g.
wrong site surgery)   
Incidents leading to death   
All incidents leading to harm   
Near miss incidents (no harm
occurred)   
Incidents regarding device failures   
Incidents regarding medication
reactions   
Hospital acquired infection incidents   
The fo l lowing types of  inc ident  should be indiv idual ly  invest igated and root  cause analysis performed. (  Please
rank in order of  pr ior i ty  for  invest igat ion)
Any fur ther comments that  you th ink may be re levant?
Medicines or devices failure reports
Incidents leading to death only
Incidents leading to death and serious harm
All incidents leading to harm
All incidents including events where no harm occurred (e.g. falls)
Never events or serious events (e.g. wrong site surgery)
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National versus local  learning
National versus local reporting and learning
These quest ions a im to  determine where learn ing f rom pat ient  safety  inc idents  is  most  va luable.
Please indicate your level  of  agreement wi th the fo l lowing statements regarding the level  at  which reports should
be col lected and learned f rom.
   Strongly disagree Disagree
Neither Agree nor
Disagree Agree Strongly Agree
All incident reports are useful to collect at
a national level.   
There should be national priorities for
reporting certain events.   
Initiatives to prevent harm should be
generated at a hospital level   
Hospitals should submit their solutions to
safety problems nationally for shared
learning.
  
Hospitals should be allowed to determine
what their own reporting priorities should
be
  
There are di fferent  ways to report  an incident .  For the fo l lowing incident  types please indicate which system is
most appropr iate for  the report  to be sent  to d i rect ly.  (Drag and drop into your preferred box)
Items National reporting system
Local/Hospital reporting system
Both national and local systems simultaneously
Separate national reporting systems
Medication errors and reactions
Device or equipment failures
Serious events or "never" events
Reports of misconduct by other
healthcare professionals.




All patient safety incident reports
leading to patient harm
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In your opin ion what type of  report ing system should the fo l lowing types of  inc ident  report  be col lected by in
order to maximise moni tor ing and learning about pat ient  safety.
   Voluntary reporting system Mandatory reporting system Not for reporting system
Medication errors and reactions   
Device or equipment failures   
Serious events or "never" events   
Reports of misconduct by other
healthcare professionals.   
Reports of staffing shortages or risk
assessments   
Near misses   
Hospital acquired infections   
All patient safety incident reports
leading to patient harm   
Any fur ther comments that  you th ink may be re levant?
Accountabil i ty and training
Accountability and training for reported patient safety incidents
We would l ike to know your v iews on who should be t ra ined to report  and who should be accountable for  deal ing
with the problems reported.
Please indicate your level  of  agreement wi th the fo l lowing statements regarding accountabi l i ty
   Strongly disagree Disagree
Neither agree nor
disagree Agree Strongly agree
Hospitals should be accountable for
investigating their own reports   
The clinical team responsible for the
patient should investigate reports
related to their own patients
  
Within each clinical specialty there
should be a lead clinician with a safety
role to promote safety solutions
  
Hospitals should have an executive
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0-5 years
5-10 years
More than 10 years
Clinical teams external to the hospital
should investigate reports of severe
patient harm
  
Please indicate how wel l  you perceive the fo l lowing heal thcare professionals are t ra ined to ident i fy  and report
safety inc idents (Tick a l l  that  apply)
   Not trained Inadequately trained Adequately trained
Nurses   
Doctors   
Other healthcare professionals   
Administrative staff   
Which heal thcare professionals should be t ra ined and encouraged to  rout inely INVESTIGATE pat ient  safety
incidents.  (Please drag and group as appropr iate)
   Strongly Disagree Disagree
Neither agree nor
disagree Agree Strongly disagree
Senior Nurses   
Junior Nurses   
Senior Doctors   
Junior Doctors   
Medical students   
Other healthcare professionals   
Administrative staff   
Managerial staff   
Any fur ther comments that  you th ink may be re levant?
Your demographic information
In which country do you work?
How many years exper ience have you had in pat ient  safety and incident  report ing ( t ick the most appropr iate)
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Have you been involved in the development of  a pat ient  safety report ing system?
What was your involvement in the report ing system? ( t ick a l l  that  apply?)
What was your level  of  involvement? ( t ick the most appropr iate)












Strongly	disagree		 Disagree	 Neutral	 	 Agree		 	 Strongly	agree	
	
You	were	neutral	about	this	statement.	Please	re-select	your	agreement	with	this	statement	
























































































































































































_______________________		 	 ________________		 	 ________________		
Name	of	Subject	 	 	 Signature	 	 	 	 Date		
	
	
________________________	 	 	________________	 	 ________________		






























_______________________		 	 ________________		 	 ________________		
Name	of	Reviewer	 	 	 Signature	 	 	 	 Date		
	
________________________	 	 	________________	 	 ________________		















a	 trained	expert	 reading	a	 case	note	 in	 full	 and	accessing	any	 further	 supplementary	 information.	
Explicit	reviews,	such	as	the	Global	Trigger	Tool,	have	also	been	used	to	detect	adverse	events.	Explicit	
methods	 use	 a	 pre-defined	 protocol	 to	 look	 for	 specific	 events.	 Explicit	 and	 implicit	 case	 review	
methods	have	been	compared	before	in	order	to	assess	quality	of	care.	In	this	study	we	will	compare	




non-expert	 clinical	 reviewers	have	 similar	 reliability	 in	assessing	avoidable	death.	A	more	protocol	
driven	method	may	safeguard	against	errors	and	explicit	 criteria	 for	 review	may	be	more	 likely	 to	
demonstrate	greater	inter-rater	reliability.		
	





















































































Trigger	 	 +	 Event	Description	
and	Severity	E-I	
	 Trigger	 	 	 		 +	 Event	Description	and	Severity	E-I	
	 	 	 	 	 	
	 General	care	module	 	 Medication	module	
G	1	 Lack	of	early	warning	score	or	early	
warning	score	requiring	response	
	 	 M	1	 Vitamin	K	 	 	
G	2	 Any	patient	fall	 	 	 M	2	 Naloxone	 	 	
G	3	 Decubiti	 	 	 M	3	 Flumazenil	 	 	
G	4	 Readmission	to	hospital	within	30	days	 	 	 M	4	 Glucagon	or	50%	glucose	 	 	





	 	 	 Lab	test	module	
	 	 Haematology	
	 Surgical	care	module	 	 L1	 High	INR	(>5)	 	 	
S	1	 Return	to	theatre	 	 	 L	2	 Transfusion	 	 	
S	2	 Change	in	planned	procedure	 	 	 	 	
L3	
Drop	in	Hb	or	Hct	(>25%)	 	 	
S3	 Removal/Injury	or	repair	of	organ	 	 	 	 Biochemistry	
	 	 	 	 L4	 Rising	urea	or	creatinine	(>2x	
baseline)	
	 	







	 	 	 	 	 	 7	 Hypoglycaemia	
(<3mmol/l)	
	 	
	 	 	 	 	 	 L8	 Raised	Troponin	(>1.5	ng/ml)	 	 	
	 	 	 	 	 	 	 Microbiology	 	 	
	 	 	 	 	 	 :L9	 MRSA	bacteraemia	
	 	 	 	 	 	 L10	 C.	difficile	 	 	
	 	 	 	 	 	 L11	 VRE	 	 	
	 	 	 	 	 	 L12	 Wound	infection	 	 	
	 	 	 	 	 	 L13	 Nosocomial	pneumonia	 	 	
	 	 	 	 	 	 L14	 Positive	blood	culture	 	 	
	
	 Intensive care module 
I 1 Readmission to ICU or HDU 	 	
I 2 Unplanned transfer to ICU or 
HDU 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Study	Aim	 Study	design	 Intervention	 Outcome	 No.	Of	
Pts	
Young-Xu	
2011	
Arch	Surg	
	
2006-
2008	
USA	
Theatre	
Surgery	
30	days	 To	reduce	surgical	
morbidity	
Retrospective	
cohort	
Medical	Team	Training	
Program	
• Risk	adjusted	morbidity	control,	reduced	from	88	per	
1000	operations	to	76	per	1000	operations	(p=0.01),	
vs.	intervention	reduced	from	97	per	1000	to	82	per	
1000	(p=0.001)	Rate	ratio	1.20	(95%	CI	1.19-1.22)	
(p=0.001)	
	
119,383	
Brannick	MT	
2009	
Acad	Med	
2006-
2007	
USA	
Simulated	
Surgery	
Not	
stated	
Decrease	errors	in	
judgement,	inattention	to	
detail	and	problem	
understanding	
Randomized	
controlled	trial	
Training	program	 • Mean	number	of	procedures/trainee	control	819.17	
(SD	71.49)	vs.	intervention	847.17(88.98)	
• Mean	complications	control	26.08	(SD	7.35)	(3.19%)	
vs.	intervention	18.00	(SD	2.53)	(2.14%)	
• Surgical	complications	decreased	over	the	course	of	
the	study	correlation	between	complications	and	time	
in	months	was	r	=	-0.47,		
14913	
McCulloch	P	
2008	
Qual	Saf	
Health	Care	
2008	 Theatre	
General	
Surgery		
12	weeks	 Effect	of	Non-technical	
skills	training	on	technical	
performance	and	
outcome	
Cohort	study	 Non-technical	skills	
training	classroom	
course	
• 48	pre-intervention,	55	post	intervention.	
• Operative	technical	errors	declined	from	1.73	to	0.98	
(u=1071,	p=0.009)	
• Non-operative	procedural	errors	declined	from	8.48	
to	5.15	per	operation	(t=4.383,	p=<0.001.	
• Mean	LOS	control	2.23	(0.7)	vs.	intervention	2.02	(0.6)	
(NS)	
• Complications	control	5/48	vs.	intervention	3/55	
103	
Stather	
2010	
Thorac	
Cardiovasc	
Surg	
2009	 Ward	
Paediatric	
Surgery	
To	
discharge	
Iatrogenic	pneumothorax	
post	chest	drain	removal.	
Cohort	study	 Re-education	and	
updated	guidelines	
including	using	
occlusive	dressing	
• 4	patients	(4.2%)	had	a	pneumothorax	post	chest	
drain	removal,		
• 1	patient	required	insertion	of	a	further	chest	drain	
for	pneumothorax,		
• One	patient	requiring	an	additional	drain	for	
recurrent	pleural	effusion		
• Pre	intervention	vs.	6/39	(15.4%)	pneumothorax	rate	
post	drain	removal	
• Chi-squared	significant	difference	(p=0.0045)	
132	
LOS=	Length	of	stay,	OR=	Odds	ratio,	95%CI	=	95%	Confidence	Interval	
	 	
	 332	
9.16.23 Extraction	tables	for	selected	studies:	Process	–Training	(part	2)		
Author	
Year	
Journal	
Year	and	
country		
Study	setting/	sub-
specialty	
Study	
Length	
Study	Aim	 Study	
design	
Intervention	 Outcome	 No.	Of	
Pts	
Goh	ES	
2009	
Int	J	Health	
Care	Qual	
Assur	
	
Singapore	 Theatre	
Ophthalmology	
30	days	 Reducing	complications	in	
cataract	surgery	
	Cohort	
study	
Regular	audit	of	
complication	rates		
• Posterior	capsule	rupture	rates	control:	3.34%	
vs.	intervention	1.53%	(p	<	0.007,	Wilcoxon	
Signed	Ranks	test)		
Not	
stated	
Stringer	B	
2009	
Pub	Health	
reports	
Canada	 Theatre	
Multi-site	
Surgery	
	
5	months	 Reducing	needle	stick,	glove	
tears	through	hands	free	
technique	
Cohort	
study	
Video	to	educate	staff	
on	hands	free	
technique	
• Hands	free	technique	use	increase	
• Decreased	adverse	events	(needle-
stick/contamination)	by	35.0%	
• OR	0.65	(95%CI	0.43-0.97)	
10,596	
Cima	
2009	
Jt	Comm	J	
Qual	Patient	
Saf.	
2005	
USA	
Theatre	
Surgery	
To	
discharge	
Reducing	retained	foreign	
objects	post	op	
Cohort	
study	
Education	program	 • Pre-intervention	average:	Retained	foreign	
object	every	16	days.		
• Post	intervention:	Average	Retained	foreign	
object	69	days	
• Sustained	for	more	than	two	years.	
Not	
stated	
LOS=	Length	of	stay,	OR=	Odds	ratio,	95%CI	=	95%	Confidence	Interval	
		
